New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease

References

• NorgrenLHiattWRDormandyJATASC II Working GroupInter-society consensus for the management of peripheral arterial diseaseInt Angiol20072628115717489079
   PubMed Web of Science ®Google Scholar
• LairdJRJainAZellerTNitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trialJ Endovasc Ther201421220221224754279
   PubMed Web of Science ®Google Scholar
• LairdJRKatzenBTScheinertDRESILIENT InvestigatorsNitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trialCirc Cardiovasc Interv20103326727620484101
   PubMed Web of Science ®Google Scholar
• LairdJRYeoKKThe treatment of femoropopliteal in-stent restenosis: back to the futureJ Am Coll Cardiol2012591242522192664
   PubMed Web of Science ®Google Scholar
• Rocha-SinghKJBosiersMSchultzGA single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trialCatheter Cardiovasc Interv201586116417025676568
   PubMed Web of Science ®Google Scholar
• SabetiSMlekuschWAmighiJMinarESchillingerMPrimary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteriesJ Endovasc Ther200512161215683273
   PubMed Web of Science ®Google Scholar
• SabetiSSchillingerMAmighiJPrimary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysisRadiology2004232251652115286322
   PubMed Web of Science ®Google Scholar
• SchillingerMSabetiSLoeweCBalloon angioplasty versus implantation of nitinol stents in the superficial femoral arteryN Engl J Med2006354181879188816672699
   PubMed Web of Science ®Google Scholar
• SchlagerODickPSabetiSLong-segment SFA stenting – the dark sides: in-stent restenosis, clinical deterioration, and stent fracturesJ Endovasc Ther200512667668416363897
   PubMed Web of Science ®Google Scholar
• DormandyJARutherfordRBManagement of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)J Vasc Surg2000311 pt 2S1S29610666287
   PubMed Web of Science ®Google Scholar
• Rocha-SinghKJJaffMRCrabtreeTRBlochDAAnselGVIVA Physicians IncPerformance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial diseaseCatheter Cardiovasc Interv200769691091917377972
   PubMed Web of Science ®Google Scholar
• SchillingerMSabetiSDickPSustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stentingCirculation2007115212745274917502568
   PubMed Web of Science ®Google Scholar
• DakeMDAnselGMJaffMRSustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studiesJ Am Coll Cardiol201361242417242723583245
   PubMed Web of Science ®Google Scholar
• DakeMDAnselGMJaffMRPaclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study resultsCirc Cardiovasc Interv20114549550421953370
   PubMed Web of Science ®Google Scholar
• DudaSHBosiersMLammerJDrug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trialJ Endovasc Ther200613670171017154704
   PubMed Web of Science ®Google Scholar
• DudaSHBosiersMLammerJSirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trialJ Vasc Interv Radiol200516333133815758128
   PubMed Web of Science ®Google Scholar
• DudaSHPusichBRichterGSirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month resultsCirculation2002106121505150912234956
   PubMed Web of Science ®Google Scholar
• ScheinertDScheinertSSaxJPrevalence and clinical impact of stent fractures after femoropopliteal stentingJ Am Coll Cardiol200545231231515653033
   PubMed Web of Science ®Google Scholar
• KleinAJChenSJMessengerJCQuantitative assessment of the conformational change in the femoropopliteal artery with leg movementCatheter Cardiovasc Interv200974578779819521998
   PubMed Web of Science ®Google Scholar
• SpeckUCremersBKelschBDo pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?Circ Cardiovasc Interv20125339240022619258
   PubMed Web of Science ®Google Scholar
• AbolaMTBhattDLDuvalSREACH InvestigatorsFate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomesAtherosclerosis2012221252753522321872
   PubMed Web of Science ®Google Scholar
• MahoneyEMWangKKeoHHReduction of Atherothrombosis for Continued Health (REACH) Registry InvestigatorsVascular hospitalization rates and costs in patients with peripheral artery disease in the United StatesCirc Cardiovasc Qual Outcomes20103664265120940249
   PubMed Web of Science ®Google Scholar
• PeacockJMKeoHHDuvalSThe incidence and health economic burden of ischemic amputation in Minnesota, 2005–2008Prev Chronic Dis201186A14122005634
   PubMed Web of Science ®Google Scholar
• TepeGZellerTAlbrechtTLocal delivery of paclitaxel to inhibit restenosis during angioplasty of the legN Engl J Med2008358768969918272892
   PubMed Web of Science ®Google Scholar
• TepeGSchnorrBAlbrechtTAngioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trialJACC Cardiovasc Interv201581 pt A10210825616822
   PubMed Web of Science ®Google Scholar
• WerkMLangnerSReinkensmeierBInhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trialCirculation2008118131358136518779447
   PubMed Web of Science ®Google Scholar
• ScheinertDDudaSZellerTThe LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplastyJACC Cardiovasc Interv201471101924456716
   PubMed Web of Science ®Google Scholar
• RosenfieldKMetzgerDCScheinertDA paclitaxel-coated balloon for femoropopliteal artery diseaseN Engl J Med2015373181785178626510036
   PubMed Web of Science ®Google Scholar
• WerkMAlbrechtTMeyerDRPaclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trialCirc Cardiovasc Interv20125683184023192918
   PubMed Web of Science ®Google Scholar
• BosiersMTorselloGGisslerHMNitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I studyJ Endovasc Ther200916326126919642788
   PubMed Web of Science ®Google Scholar
• LiistroFGrottiSPortoIDrug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)JACC Cardiovasc Interv20136121295130224239203
   PubMed Web of Science ®Google Scholar
• LairdJRSchneiderPATepeGIN PACT SFA Trial InvestigatorsSustained durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFAJ Am Coll Cardiol201566212329233826476467
   PubMed Web of Science ®Google Scholar
• TepeGLairdJSchneiderPDrug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trialCirculation2015131549550225472980
   PubMed Web of Science ®Google Scholar
• ScheinertDSchulteKLZellerTLammerJTepeGPaclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trialJ Endovasc Ther2015221142125775674
   PubMed Web of Science ®Google Scholar
• SchroederHMeyerDRLuxBRueckerFMartoranaMDudaSTwo-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human studyCatheter Cardiovasc Interv201586227828625708850
   PubMed Web of Science ®Google Scholar
• LepantaloMMatzkeSOutcome of unreconstructed chronic critical leg ischaemiaEur J Vasc Endovasc Surg19961121531578616645
   PubMed Web of Science ®Google Scholar
• WolfeJHWyattMGCritical and subcritical ischaemiaEur J Vasc Endovasc Surg19971365785829236711
   PubMed Web of Science ®Google Scholar
• BerteleVRoncaglioniMCPangrazziJTerzianETognoniEGClinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia GroupEur J Vasc Endovasc Surg199918540141010612642
   PubMed Web of Science ®Google Scholar
• BeckmanJACreagerMACritical limb ischemia and intermediate-term survivalJACC Cardiovasc Interv20147121450145225523537
   PubMed Web of Science ®Google Scholar
• SogaYIidaOTakaharaMTwo-year life expectancy in patients with critical limb ischemiaJACC Cardiovasc Interv20147121444144925523536
   PubMed Web of Science ®Google Scholar
• MoxeyPWBrownriggJKumarSSThe BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scoresJ Vasc Surg20135711723040797
   PubMed Web of Science ®Google Scholar
• SchmidtAUlrichMWinklerBAngiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial diseaseCatheter Cardiovasc Interv20107671047105420518006
   PubMed Web of Science ®Google Scholar
• FernandezNMcEnaneyRMaroneLKMultilevel versus isolated endovascular tibial interventions for critical limb ischemiaJ Vasc Surg201154372272921803523
   PubMed Web of Science ®Google Scholar
• SoderstromMIArvelaEMKorhonenMInfrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysisAnn Surg2010252576577321037432
   PubMed Web of Science ®Google Scholar
• SpreenMIMartensJMHansenBEPercutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia (PADI) trialCirc Cardiovasc Interv201692e00237626861113
   PubMed Web of Science ®Google Scholar
• SchmidtAPiorkowskiMWernerMFirst experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcomeJ Am Coll Cardiol201158111105110921884945
   PubMed Web of Science ®Google Scholar
• LiistroFPortoIAngioliPDrug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemiaCirculation2013128661562123797811
   PubMed Web of Science ®Google Scholar
• ZellerTBaumgartnerIScheinertDDrug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trialJ Am Coll Cardiol201464151568157625301459
   PubMed Web of Science ®Google Scholar
• Available from: http://vascularnews.com/the-in-pact-deep-trial-putting-the-results-into-context/?s=in.pact+deep+trialAccessed June 2, 2016
   Google Scholar
• ZellerTBeschornerUPilgerEPaclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK’S-first in man study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)JACC Cardiovasc Interv20158121614162226493253
   PubMed Web of Science ®Google Scholar